Cyclodextrin-Based Oral Solution of Ursodeoxycholic Acid Using a Ready-to-Use Vehicle
Researchers from Italy and Argentina developed a HPBCD-based oral solution of ursodeoxycholic acid (UDCA), a bile acid widely used for
A forum for researchers, students and applicants in the field of cyclodextrin technology
Researchers from Italy and Argentina developed a HPBCD-based oral solution of ursodeoxycholic acid (UDCA), a bile acid widely used for
This study (1) aims to build on previously published results that characterized cholesteryl-modified β-cyclodextrin (CD21chol) as a carrier for 5-fluorouracil. (2)
Two types of hydroxypropylated CD (HPβCD and HPγCD) were used to create electrospun nanofibers with two different molar ratios (1:1
Traditional chitosan hydrogels are highly biocompatible but too hydrophilic to effectively load and sustain release of hydrophobic drugs. In a
The authors hypothesized that integrating tumor-targeted topoisomerase I inhibitor delivery with optimized PARP inhibitor scheduling could enable effective combination therapy
Cyclodextrins (CDs) have undergone a remarkable evolution over the past three decades, transitioning from classical solubilizing agents to multifunctional platforms
The co-delivery of rivastigmine hydrogen tartrate (RHT) and asiaticoside (AS) offers a promising strategy for enhancing acetylcholinesterase (AChE) inhibition in
Porphyrins are powerful photosensitive molecules with useful photophysical and redox properties, making them attractive for therapeutic use. However, they often
Researchers in Mexico compared two food-grade nanosuspension formulations for oral delivery of acetogenins (ACGs), a potent but poorly soluble class
Fungal keratitis (FK) is a leading cause of corneal blindness worldwide. Although voriconazole (VOR) is effective, its poor corneal permeability